000 01676 a2200541 4500
005 20250517083213.0
264 0 _c20170221
008 201702s 0 0 eng d
022 _a1474-1784
024 7 _a10.1038/nrd.2016.28
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMillan, Mark J
245 0 0 _aAltering the course of schizophrenia: progress and perspectives.
_h[electronic resource]
260 _bNature reviews. Drug discovery
_c07 2016
300 _a485-515 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAntipsychotic Agents
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aSchizophrenia
_xdiagnosis
700 1 _aAndrieux, Annie
700 1 _aBartzokis, George
700 1 _aCadenhead, Kristin
700 1 _aDazzan, Paola
700 1 _aFusar-Poli, Paolo
700 1 _aGallinat, Jürgen
700 1 _aGiedd, Jay
700 1 _aGrayson, Dennis R
700 1 _aHeinrichs, Markus
700 1 _aKahn, René
700 1 _aKrebs, Marie-Odile
700 1 _aLeboyer, Marion
700 1 _aLewis, David
700 1 _aMarin, Oscar
700 1 _aMarin, Philippe
700 1 _aMeyer-Lindenberg, Andreas
700 1 _aMcGorry, Patrick
700 1 _aMcGuire, Philip
700 1 _aOwen, Michael J
700 1 _aPatterson, Paul
700 1 _aSawa, Akira
700 1 _aSpedding, Michael
700 1 _aUhlhaas, Peter
700 1 _aVaccarino, Flora
700 1 _aWahlestedt, Claes
700 1 _aWeinberger, Daniel
773 0 _tNature reviews. Drug discovery
_gvol. 15
_gno. 7
_gp. 485-515
856 4 0 _uhttps://doi.org/10.1038/nrd.2016.28
_zAvailable from publisher's website
999 _c25793027
_d25793027